Radiologic-pathologic correlation in breast cancer: do MRI biomarkers correlate with pathologic features and molecular subtypes?

[1] Harbeck N(2017)Breast cancer Lancet 18 1134-1150

[2] Gnant M(2015)Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy Of Early Breast Cancer 2015 Ann Oncol 26 1533-1546

[3] Coates AS(2014)Molecular classification of breast cancer Virchows Arch 465 1-14

[4] Winer EP(2016)Immunohistochemical surrogates for molecular classification of breast carcinoma: a 2015 update Arch Pathol Lab Med 140 806-814

[5] Goldhirsch A(2013)Panel Members. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer Ann Oncol 24 2206-2223

[6] Vuong D(2018)Multiparametric MRI of the breast: a review J Magn Reson Imaging 47 301-315

[7] Simpson PT(2020)Can MRI biomarkers predict triple-negative breast cancer? Diagnostics (Basel) 10 1090-60

[8] Green B(2020)Peritumoral edema as a biomarker of the aggressiveness of breast cancer: results of a retrospective study on a 3 T scanner Breast Cancer Res Treat 181 53-428

[9] Cummings MC(2017)MR imaging findings in molecular subtypes of breast cancer according to BIRADS system Breast J 23 421-339

[10] Lakhani SR(2012)Magnetic resonance imaging features in triple-negative breast cancer: comparison with luminal and HER2-overexpressing tumors Clin Breast Cancer 12 331-1528

[1] Harbeck N(2017)Breast cancer Lancet 18 1134-1150

[2] Gnant M(2015)Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy Of Early Breast Cancer 2015 Ann Oncol 26 1533-1546

[3] Coates AS(2014)Molecular classification of breast cancer Virchows Arch 465 1-14

[4] Winer EP(2016)Immunohistochemical surrogates for molecular classification of breast carcinoma: a 2015 update Arch Pathol Lab Med 140 806-814

[5] Goldhirsch A(2013)Panel Members. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer Ann Oncol 24 2206-2223

[6] Vuong D(2018)Multiparametric MRI of the breast: a review J Magn Reson Imaging 47 301-315

[7] Simpson PT(2020)Can MRI biomarkers predict triple-negative breast cancer? Diagnostics (Basel) 10 1090-60

[8] Green B(2020)Peritumoral edema as a biomarker of the aggressiveness of breast cancer: results of a retrospective study on a 3 T scanner Breast Cancer Res Treat 181 53-428

[9] Cummings MC(2017)MR imaging findings in molecular subtypes of breast cancer according to BIRADS system Breast J 23 421-339

[10] Lakhani SR(2012)Magnetic resonance imaging features in triple-negative breast cancer: comparison with luminal and HER2-overexpressing tumors Clin Breast Cancer 12 331-1528